Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Crane

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium StudyQuisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancerJillian R Gunther, Awalpreet S Chadha, Sushovan Guha, et al.
Journal of Clinical Medicine|May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive SurgeryEdward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811Corinne M Doll, Jennifer Moughan, Alexander Klimowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
International Journal of Colorectal Disease|July 23, 2021
Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancerRosa M Jimenez-Rodriguez, Jonathan B Yuval, Charles-Etienne Gabriel Sauve, et al.
JCO Precision Oncology|September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic CancerEugene J Koay, Matthew H G Katz, Huamin Wang, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium StudyQuisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancerJillian R Gunther, Awalpreet S Chadha, Sushovan Guha, et al.
Journal of Clinical Medicine|May 11, 2024
Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive SurgeryEdward Christopher Dee, Victor C Ng, Eileen M O'Reilly, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811Corinne M Doll, Jennifer Moughan, Alexander Klimowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
International Journal of Colorectal Disease|July 23, 2021
Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancerRosa M Jimenez-Rodriguez, Jonathan B Yuval, Charles-Etienne Gabriel Sauve, et al.
JCO Precision Oncology|September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic CancerEugene J Koay, Matthew H G Katz, Huamin Wang, et al.
Pageof 31